It's good to see many of the regulars still on the board providing excellent technical advice.
China Biopharma is getting wedged today into the last days of what looks to be a pennant formation. The next day or so should tell us whether it's a breakout or breakdown.
Market cap is low at around $4MM and does a good job of filing SEC reports, so I don't see a de-listing anytime soon. Also, this could be a good play in the viral, superbug (MRSA) and bird-flu space.
Anyway worth a look from a technical perspective.
Good luck!
poorman1 ;)
Looks like this puppy wants to move much higher after bouncing off the 50 DMA.
Good luck!